Research Partnership, an Inizio Advisory company, worked with their client to develop a trackable index for patients newly diagnosed with multiple myeloma to track and measure the patient experience, including unmet needs, access barriers and burden of the disease at various stages.
Read more about the client’s challenge, Research Partnership’s solution and the outcomes.
Discover more about how we help to shape the future of oncology treatments here.
Our client was new to the complement system space and was preparing to launch an oral, first-in-class medication in a rare blood disease.
Read moreA top 10 pharma company wanted dermatologists to own the conversation on PsA, and become confident in diagnosing the disease.
Read moreA top 10 global pharma company wanted to challenge the status quo when it came to planning and prioritizing congresses.
Read more